We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vycor Medical Inc (QB) | USOTC:VYCO | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0899 | 0.061 | 0.0899 | 0.00 | 13:30:25 |
CUSIP No. 92921M203
|
13D
|
1.
|
NAMES OF REPORTING PERSONS
Fountainhead Capital Management Limited
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
o
(b)
o
|
3.
|
SEC USE ONLY
|
4.
|
SOURCE OF FUNDS
OO (See Item 3 below)
|
5.
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
o
|
6.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Jersey, Channel Islands
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
7.
|
SOLE VOTING POWER 6,497,818
|
8.
|
SHARED VOTING POWER 0
|
|
9.
|
SOLE DISPOSITIVE POWER 6,497,818
|
|
10.
|
SHARED DISPOSITIVE POWER 0
|
11.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
6,497,818
|
12.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
|
13.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
49.59%
|
14.
|
TYPE OF REPORTING PERSON
CO
|
(a)
|
The Reporting Person is the beneficial owner of 6,497,818 shares of the Company’s common stock, representing 49.59% of the outstanding shares of the Company’s common stock. Said amount includes all shares issuable to the Reporting Person on account of all Warrants held by the Reporting Person convertible or exercisable within sixty (60) days of the date of this report. Other than as described therein, the Reporting Person does not own any other securities of the Company. The holder believes the number of shares of the Company’s outstanding common stock to be 11,054,735 as of July 1, 2016.
|
(b)
|
The Reporting Person has the sole power to vote and dispose of the 6,497,818 shares, less the number of shares which are currently subject to issuance only upon the exercise of Warrants.
|
(c)
|
Except for the transactions described in the Explanatory Note above, the Reporting Person did not effect any transactions in the issuer’s securities within the past 60 days.
|
(d)
|
No other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Reporting Person’s securities.
|
(e)
|
Not applicable.
|
Dated: July 12, 2016
|
||
By:
|
/s/
Mark Andrews
|
|
Name: Mark Andrews for and on behalf of Berwin Limited, Director
|
||
By:
|
/s/ Eileen O’Shea
|
|
Name: Eileen O’Shea, for and on behalf of Moulton imited, Director
|
1 Year Vycor Medical (QB) Chart |
1 Month Vycor Medical (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions